NYSE: PRIPrimerica Inc Stock
$247.08-7.47 (-2.93%)
Updated Apr 21, 2025
PRI Price
$247.08
Fair Value Price
N/A
Market Cap
$8.22B
52 Week Low
$211.53
52 Week High
$307.91
P/E
18x
P/B
3.64x
P/S
3x
PEG
0.85x
Dividend Yield
1.45%
Revenue
$3.09B
Earnings
$470.52M
Gross Margin
79.9%
Operating Margin
23.13%
Profit Margin
15.2%
Debt to Equity
5.46
Operating Cash Flow
$862M
Beta
0.98
Next Earnings
May 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PRI Overview
Primerica, Inc. offers term life insurance, investment and savings, and senior health products to middle-income households in the U.S. and Canada. The company's operating subsidiaries are Primerica Life Insurance Company, National Benefit Life Insurance Company, and Primerica Life Insurance Company of Canada (Primerica Life Canada).The company's products are sold through a network of 129,515 licensed sales representatives. Primerica was founded in 1927 and is headquartered in Duluth, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PRI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Property & Casualty Insurance
Industry Rating
C
PRI
Ranked#8 of 19
Ranked#8 of 19
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $20.49 | B | |
| $117.17 | C | |
| $48.79 | C |
Be the first to know about important PRI news, forecast changes, insider trades & much more!
PRI News
Overview
Due Diligence Score
–
Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PRI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PRI ($247.08) is trading above its intrinsic value of $175.46, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PRI is good value based on its earnings relative to its share price (18x), compared to the US market average (27.14x)
P/E vs Market Valuation
PRI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PRI due diligence checks available for Premium users.
Valuation
PRI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
18x
Industry
11.59x
Market
27.14x
PRI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PRI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PRI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.64x
Industry
1.43x
PRI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PRI price to earnings growth (PEG)
For valuing profitable companies with growth potential
PRI is good value based... subscribe to Premium to read more.
PEG Value Valuation
PRI's financial health
Profit margin
Revenue
$788.1M
Net Income
$167.1M
Profit Margin
21.2%
PRI's Earnings (EBIT) of $714.67M... subscribe to Premium to read more.
Interest Coverage Financials
PRI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.6B
Liabilities
$12.3B
Debt to equity
5.46
PRI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PRI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$270.6M
Investing
-$50.7M
Financing
-$79.4M
PRI's operating cash flow ($862.09M)... subscribe to Premium to read more.
Debt Coverage Financials
PRI vs Property & Casualty Insurance Stocks
Primerica Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.